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Abstract 
Background: Little is known about the relationship between brain volumes and 
neurodevelopmental outcome at two years of age in children with single ventricle congenital 
heart disease (CHD). We hypothesized that reduced brain volumes may be associated with 
adverse neurodevelopmental outcome. 
Methods: Volumetric segmentation of cerebral MRI scans was done in 44 patients without 
genetic comorbidities and in eight controls. Neurodevelopmental outcome was assessed with the 
Bayley-III scales.  
Results: Gray matter (GM), deep GM, white matter (WM), and cerebrospinal fluid (CSF) 
volumes were 611 ±59 ml, 43 ±4.5 ml, 277 ±30 ml, and 16.4 ml (IQR 13.1, 23.3 ml). Children 
undergoing neonatal cardiopulmonary bypass surgery showed smaller deep GM (p=0.005) and 
WM (p=0.021) volumes. Brain volumes were smaller in patients compared to controls (GM: 
p=0.017, deep GM: p=0.012, WM: p=0.015), whereas CSF volumes were greater (p=0.014). Of 
all intracranial volumes, only CSF volume was associated with neurodevelopmental outcome, 
accounting for 21% (p=0.011) of variability in the cognitive composite score when combined 
with common risk factors in a multivariable analysis. 
Conclusion: Increased CSF volume represents a significant risk factor for neurodevelopmental 
impairment in children with single ventricle CHD. Later assessments are warranted to determine 
the prognostic role of intracranial volumes for long-term outcome. 
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Introduction 
Children with single ventricle (SV) congenital heart disease (CHD) including hypoplastic left 
heart syndrome (HLHS) are at high risk for delayed intrauterine brain development as well as 
perioperative cerebral injuries (1–3). Brain injuries and delayed maturation seen in patients with 
complex CHD can be detected by cerebral magnetic resonance imaging (MRI), and may cause 
neurodevelopmental impairments (4,5).  
In addition to providing qualitative information about the presence of brain lesions, atrophy, and 
other abnormalities, emerging MRI techniques also allow for the quantitative measurement of 
global and regional brain volumes (6). The association between global and regional brain 
volumes and neurodevelopmental function in children with CHD has been investigated in 
infancy (7,8), in adolescence (9), and in adulthood (10). Recently, we observed cerebrospinal 
fluid (CSF) enlargement in children with SV before Fontan completion which correlated strongly 
with poorer neurodevelopmental functioning at 2 to 3 years of age (11). In adolescence, 
structural abnormalities (atrophy or focal infarction) were associated with neuropsychological 
deficits in patients who underwent Fontan completion (12). However, at two years of age, which 
is an important time period for cognitive, language, and motor development, studies comparing 
brain volumetric measurements and developmental data in patients with SV CHD are lacking. 
Therefore, we quantified brain volumes in children with SV prior to Fontan completion using the 
Freesurfer software and compared the resulting volumes to neurodevelopmental outcome scores, 
in order to evaluate the relationship between brain volumes and neurodevelopment as well as 
growth in high-risk (SV) CHD patients during the vulnerable phase of brain development 
between infancy and early childhood. 
 
Methods 
Study Design 
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This retrospective cohort study is part of a two-center collaboration (University Children´s 
hospital, Pediatric heart center, Giessen, Germany, Center A; University Children’s hospital of 
Zurich, Switzerland, Center B) investigating structural and functional neurological and 
neurodevelopmental status before Fontan completion in patients with SV without known 
underlying genetic comorbidities. Within a part of the original study population (n=47 (11)) 
enrolled between August 2012 and July 2015, we performed a secondary volumetric MR 
analysis in 44 patients and eight controls. The volumetric analysis was not feasible in one patient 
receiving a 1.5 Tesla scan and in two patients with missing high-resolution 3D MR sequences. 
Demographic characteristics from the excluded children did not differ from those included. The 
control patients (63% from Center A) were scanned for headache (3), afebrile, primary 
generalized epileptic seizures (2), suspected epilepsy, not confirmed in follow-up (1), recurrent 
vomiting (1), dermatologic lesions (1). However, all had a normal cerebral MRI scan and 
neurocognitive development. The study protocol conforms to the ethical guidelines of the 1975 
declaration of Helsinki as reflected in a priori approval by the local ethics committee and written 
informed consent provided by parents or caregivers. 
As previously described (11), the patient characteristics were abstracted from the patient charts, 
socioeconomic status was evaluated according to Largo et al. (13), and anthropometric 
measurements were transformed into age- and gender-adjusted Z-scores (14).  Microcephaly and 
head growth restriction were defined from Z-scores below the third and tenth percentiles, 
respectively. The patient characteristics are presented in Table 1. Additionally, the use or 
duration of any of the following treatments was recorded: length of cumulative hospital stay, 
cumulative mechanical ventilation, and number of cardiac reinterventions.  
Neurodevelopmental assessments 
Prior to the MRI scan, children of the study group were assessed with the Bayley Scales of Infant 
and Toddler Development Version III (Bayley-III) by an experienced developmental pediatrician 
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or neurologist (BL, KW) at each center (15). The Bayley-III scales measure cognition (Cognitive 
Composite Scale, CCS), language (Language Composite Scale, LCS) and motor function (Motor 
Composite Scale, MCS). Normative composite scores were calculated by age for each scale and 
compared to American test norms (mean 100 points, SD 15). For all scales, cut-off points of < 85 
(1 SD below normative mean) equivalent to mild to moderate impairment, and < 70 (2 SD below 
normative mean) considered as severe impairment were used, respectively (15). All children had 
a neurological examination that was scored according to severity (normal, reflex or tone 
abnormality, reflex and tone abnormality or cerebral palsy) (16). 
Cerebral MRI and brain volumetry 
Cerebral MRI data including high-resolution 3D T1-weighted images (Center A: magnetization 
prepared rapid acquisition gradient echo, MP-RAGE; Center B: spoiled gradient echo, SPGR) 
were acquired before Fontan completion at a mean age of 26.7 months, SD 3.9, and in eight 
controls (5 male, 62.5%) at a mean age of 29.8 months, SD 9.5 (p=0.21). Intracranial structural 
anomalies were described elsewhere (11). The 3D T1 images were anatomically segmented into 
gray matter (GM), white matter (WM), and CSF maps and the volumes of each tissue 
compartment were calculated with the Freesurfer image analysis suite (Martinos Center for 
Biomedical imaging, Massachusetts, U.S.; http://surfer.nmr.mgh.harvard.edu/) on a Linux 
workstation. Total brain volume (TBV) was defined as intracranial volume (ICV) without CSF. 
The Freesurfer software has been evaluated and established as a robust tool for quantification of 
cerebral volumes in children with CHD at two years of age, showing high accuracy and 
reliability in a recent validation study (17).  
Statistical Analyses 
Statistical analyses were performed with IBM SPSS Statistics for Macintosh, version 23 (IBM 
Corp., Armonk, N.Y.). With the respective measures of dispersion, descriptive statistics are 
presented as mean, SD or median, IQR for continuous variables, and as frequency and 
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percentage for categorical variables. A Shapiro-Wilk test was used to test normality. The t-test or 
the Mann-Whitney-U test was applied to calculate differences between groups as appropriate 
based on the dispersion of the data. Significant differences between brain volume and 
neurodevelopment were then checked after adjusting for age, gender and center using 
ANCOVA. Correlations of brain volumes with anthropometric measures and neurologic 
outcome, as well as previously defined patient related and perioperative risk factors were 
analyzed with a Pearson’s correlation for normally distributed variables and Spearman’s rho for 
non-normally distributed data. We controlled for age, center and gender using bivariate 
correlations. For identification of influence of intracranial volumes on neurodevelopmental 
outcome, a multivariable linear regression model was used, for which all non-normally 
distributed interval data were logarithmically transformed (using a natural logarithm). A 
significance level of 0.05 was applied.  
 
Results  
Patient characteristics  
Forty-four patients (28 male, mean age 26.7 months, SD 3.9) were included in the study. Mean 
gestational age was 39.2 weeks, SD 1.5. Two patients (4.5%) were born at 34 1/7 and 36 3/7 
gestational weeks, respectively. Twenty-three patients were treated in Center A and 21 in Center 
B. Patient characteristics are shown in Table 1. More than half of all patients (56.8%) had a 
prenatal diagnosis of their CHD. Cardiac diagnosis included SV, of which HLHS was the most 
common (56.8%; for detailed cardiac diagnoses see supplemental Table S1). There was a higher 
prevalence of HLHS at Center A (20 versus 5), where patients were treated more frequently with 
the Hybrid approach (p<0.001) at a younger age for both, stage I and stage II surgery (p Stage I = 
0.006, p Stage II = 0.001). The remainder patient characteristics did not differ between the two 
study centers.  
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Children with SV CHD are treated by a three-staged surgical palliation completed by the Fontan 
operation at two to three years of age with complete separation of passive pulmonary blood flow. 
Of our cohort, twenty-four patients were treated with Hybrid stage I procedure (catheter-guided 
stenting of patent arterial duct and surgical bilateral pulmonary banding) followed by 
Comprehensive stage II (removal of patent arterial duct stent and pulmonary artery bands, 
enlargement of the aortic arch, bidirectional cavopulmonary anastomosis). Six patients received 
classical stage I Norwood procedure (atrial septectomy, pulmonary artery to aortic arch shunt, 
aortic arch repair) and ten patients had other systemic-to-pulmonary shunt surgery (modified 
Blalock-Taussig shunt, systemic ventricular to pulmonary artery shunt, pulmonary artery 
banding) as stage I procedure, followed by bidirectional cavopulmonary anastomosis (Glenn 
procedure) as stage II procedure. Four patients did not undergo a stage I cardiac procedure due to 
balanced hemodynamics (reduced pulmonary artery flow due to pulmonary stenosis) during the 
neonatal period, and received Glenn procedure on cardiopulmonary bypass (CPB) as stage II. 
Ten (22.7%) patients underwent their first CPB surgery during the neonatal period at a mean age 
of 10.5 days, SD 7, including six patients with classical Norwood procedure, two HLHS patients, 
who first followed the Hybrid approach but received a secondary surgical atrial septectomy later 
on, and two SV patients treated by Blalock–Taussig shunt surgery, with need for PDA closure in 
one patient and atrial septectomy in the other patient. Age at stage I did not differ whether the 
surgery was done with or without CPB (p=0.13).  
There was need for re-catheterization in 14 (32.8%) patients after stage I and in 13 (29.5%) after 
stage II, as well as for re-operation in 13 (29.5%) patients, after stage I, and II, respectively.  
Growth 
At birth, all growth measurements were restricted as indicated by mean Z-scores below reference 
values (weight p=0.02, height p<0.001, HC p=0.008; Figure 1). The mean HC at birth was on the 
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34
th
 percentile (mean Z-score -0.42), with seven (15.9%) patients below the 10
th
 percentile and 
four (9.1%) patients with microcephaly (below the 3
rd
 percentile).  
There was a growth spurt in all growth parameters after stage II operation. However, at the age 
of two to three years mean body weight (33
th
 percentile, Z-score -0.45) and height (18
th
 
percentile, Z-score -0.90) remained significantly below normative values (p-values both <0.001; 
Figure 1), whereas, HC showed a complete catch-up in growth towards reference values at that 
age (55
th
 percentile, Z-score 0.13; p=0.40). The HC correlated strongly with CSF volume 
(r=0.45, p=0.002) but not with total brain volumes, Bayley-III scales or with neurological 
abnormality (all p-values >0.05, Table 3). 
Neurodevelopmental outcome 
The median Bayley-III scores were all comparable to normative data: Median CCS was 100 
(IQR 90-105), LCS 97 (IQR 86-106), and MCS 97 (IQR 88-107) (all p-values >0.05). For CCS, 
two (4.5%) children had scores below 85, and two (4.5%) were below 70. For LCS eight (18.2%) 
children were below 85 and one (4.5%) was below 70. For MCS seven (15.9%) were below 85, 
and three (12.6%) were below 70.  
Intracranial volumes  
Intracranial volumes are presented in Table 2. Compared to age-matched controls, all brain 
volumes were decreased in children with CHD (Table 2). Deep GM and WM volumes were 
reduced if stage I was performed with CPB during the neonatal period (Figure 2). Volumes for 
children with and without neonatal CPB were 39.7ml, SD 4.0, and 43.5ml, SD 4.3 for deep GM 
(p=0.005), and 255.5ml, SD 21.3, and 283.5ml, SD 28.8 for WM (p=0.021), respectively. 
Patients with gray or white matter lesions did not have larger CSF volumes compared to those 
without lesions (p=0.30). Of note, all brain volumes were highly intercorrelated (GM with WM: 
r=0.83, GM with deep GM r=0.71, WM with deep GM r=0.72, all p-values <0.001), while CSF 
volume did not correlate with other intracranial volumes (with GM: r=0.09, p=0.58; deep GM: 
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r=0.04, p=0.81; WM: r=0.14, p=0.38). Of all intracranial volumes, only CSF volume correlated 
with neurodevelopmental outcome (Figure 3 and Table 3) (CCS p=<0.001, LCS p=0.019, MCS 
p=0.002). In a multivariable model combined with previously identified risk factors for impaired 
neurocognitive function (SES, head circumference at birth, number of reinterventions, length of 
hospital stay and mechanical ventilation), CSF contributed up to 21% of variability in the CCS 
outcome (p=0.011). 
 
Discussion 
In this study, brain volumes of children with CHD and healthy controls were measured by a 
morphometric MRI technique at two to three years of age. The main finding of our study is that 
children with SV CHD showed reduced brain volumes and increased CSF volumes compared to 
healthy controls. Importantly, neurodevelopmental outcome showed Bayley-III median scores 
comparable to normative data. Of all intracranial volumes, only CSF volume correlated 
negatively with the neurodevelopmental performance. We did not find any association between 
brain tissue volumes (GM, deep GM or WM) or HC with neurodevelopmental outcome scores, 
as previously described for infants (18) and adolescents (9) with CHD. 
Complete catch-up growth of HC at time of the MRI scan, most likely does not represent normal 
brain development, since HC only correlated strongly with CSF volume, however, not with total 
brain matter at two to three years of age. HC catch-up growth in SV CHD patients is probably 
not a reliable parameter, since it did not correlate with neurodevelopment at that age. Thus, more 
sensitive brain imaging techniques are needed to elucidate intracranial volume changes and 
reduction of cell mass in certain brain regions. Our findings offer new insights into the extent of 
CSF enlargement and the development of white and gray matter structures.  
Interestingly, neonatal CPB was associated with a significant reduction of deep GM and WM 
volumes. Our data suggest that neonatal CPB surgery might have led to a reduction of brain 
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volumes at two years of age prior to the Fontan completion. It is well known that deep and 
periventricular cerebral regions are highly susceptible to chronic hypoxia-ischemia during the 
first months of life (19). Neuropathological studies revealed that brain disturbances in children 
with complex CHD before surgery are dominated by cerebral white matter injury (20,21). Brain 
abnormalities in CHD patients, similar to those in preterm infants, originate and evolve over the 
last trimester of gestation and are caused by hypoxia-ischemia, are primarily chronic, and 
involve a complex amalgam of destructive and developmental disturbance, affecting the white 
matter and multiple neuronal/axonal structures (22). Moreover, subplate neurons, a transient 
population of neurons beneath the cortical plate, develop rapidly in the last trimester in the 
human brain (23). These neuronal cells play an important role in the development of 
thalamocortical, corticocortical, and commissural cortical fibers (24). Subplate neurons have 
been shown to be vulnerable to hypoxia-ischemia in a neonatal rat model (25). Various 
preoperative cerebral lesions are found to be accentuated after CPB (26). Furthermore, the 
shorter postoperative care after hybrid approach or no neonatal surgery in cases of SV with 
balanced hemodynamic compared to a CPB operation is less invasive for the newborn patient. 
Open-heart surgery in the neonatal period is characterized by numerous blood transfusions, 
hemodynamic and coagulation imbalances, inflammatory responses, catecholamine infusions, 
longer mechanical ventilation, pain and sedation medication, among other risk factors. It is well 
known that cerebral ischemia/reperfusion (27), oxidative stress, combined with the propensity 
for impaired vascular autoregulation in the immature brain (28), infection/inflammatory 
processes and certain medication (e.g. fentanyl and volatile anesthetics (5,29) can cause neonatal 
brain injury. Postponing the time of CPB from the more critical neonatal time period towards 
infancy at 4 to 6 months of age might result in higher maturational stage of the developing brain 
and may contribute to a lessened susceptibility of these structures towards perioperative cerebral 
©    2017 Macmillan Publishers Limited. All rights reserved.
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damage (30). The adverse effect of neonatal CPB on the immature brain as a potential risk factor 
for consecutive neurodevelopmental outcome has been suggested by Sakamoto (31).  
In contrast, Beca et al. have shown that new WMI occurred in the same rate in infants 
undergoing surgery with and without CPB (32). However,  the predominant cell death pathway 
for immature brain cells is apoptosis and autophagy (33). Conventional MRI will not be able to 
detect this consecutive brain cell loss, that might have occurred during stage I operation in the 
neonatal period.  
A downside of the hybrid approach might be the prolongation of the intrauterine conditions by 
stenting the duct and maintaining the retrograde perfusion via the hypoplastic aortic arch. 
Depending on the size of the aortic arch, the brain perfusion is not improved. This may result in 
maturation delay of the white and subcortical grey matter.  
Increased CSF and smaller brain volumes are indicative of impairment in brain growth and brain 
development. Both changes have been shown in patients with SV during fetal life (2,3), in 
newborns (7), and in adults (10).  Our finding that increased CSF volumes are significantly 
associated with poorer neurodevelopmental outcome is consistent with recent findings by Owen 
et al., who reported a relationship between poor behavioral state regulation, greater CSF volumes 
and reduced deep GM in cyanotic CHD in neonates with complex CHD before bypass surgery 
(7).  
Impaired prenatal brain development with a disproportionate increase of CSF volumes (1–3), and 
parenchymal as well as metabolic abnormalities (1) has been observed in children with CHD 
during the third trimester. In this period of rapid brain growth the maturing oligodendrocytes are 
highly sensitive to hypoxia/ischemia. Animal studies have shown that chronic hypoxia/ischemia 
is one of the key pathogenic factors of microstructural dysmaturation with disruption of neuronal 
connectivity (34). Hence, periventricular WMI might contribute to secondary ventriculomegaly 
(35). The delay in brain maturation of about four to five weeks in children with HLHS and other 
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complex CHD at term (4) might further increase brain vulnerability against hypoxic-ischemic 
injuries (36,37). Premyelinating, immature oligodendrocytes are vulnerable during the last 
trimester, characterized by extensive oligodendrocyte migration and maturation.  
In addition to ischemic-hypoxic brain injury, altered hemodynamic state with a central venous 
pressure increase after stage II procedure may lead to diffuse brain injury and CSF increase (38) 
in some patients with SV CHD. At pivotal interacting structures between the cardiovascular 
circulation and the CSF spaces (i.e. cerebral arteries, capillaries of the plexus choroideus (CSF 
secretion), absorption sites at the arachoid granulations and venous sinuses, and autonomic brain 
regulatory nuclei in the deep GM) (39) altered hemodynamics may contribute to isolated CSF 
space enlargement in children with complex CHD. This may result in an imbalance in cardiac 
impulse distribution, and disturbance of the cerebral auto-regulation (deficient 'Windkessel 
effect') (38). Increased mean venous pressure after stage II procedure may lead to disturbed CSF 
resorption, and may contribute to chronic congestion as suggested by the pulsation theory (39). 
Studies measuring intracranial pulse waves may be able to elucidate the interaction of the 
complex hemodynamic state and brain growth in the future. Whether the increase in CSF volume 
is the result of underlying diffuse brain injury due to microstructural changes needs to be further 
investigated with more sophisticated imaging techniques or animal studies. 
 
Methodological considerations 
The favorable neurodevelopmental outcome compared to former outcome studies of children 
with complex heart disease highlights the recent progress in well-adapted surgical treatment and 
perioperative care of children with CHD of SV physiology. However, these results should be 
interpreted with caution as it has been shown that the Bayley-III Scales overestimate cognitive 
outcome compared to the Bayley Scales of Infant Development-II (40), confounding direct 
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comparisons of neurodevelopmental outcomes assessed with the Bayley-III to those reported 
previously with the Bayley-II.  
Limitations to our study arise from the non-randomized study design. Criteria for the choice of 
the surgical approach may influence the outcome depending on the surgeon’s decision to allocate 
certain patients to certain surgical procedures.  
Our study is further limited by the small size and inhomogeneity of our patient population, 
particularly with regard to cardiac diagnoses and surgical procedures. Given the small sample 
size, some apparently significant correlations might have occurred by chance. We used a 
retrospective study design and studied intracranial volumes at two to three years of age, which 
precludes the observation of volumetric changes over time and their association with 
anthropometric data at birth. The cross-sectional study design limits the validity of intracranial 
volumes as predictor of further neurodevelopmental outcome. Further, we did not examine 
regional volumes or shapes of different brain structures, which may be relevant for future 
analyses.  
 
 
Conclusions 
Brain volumes of children with SV CHD prior to the Fontan completion are smaller compared to 
controls. Those undergoing CPB surgery during the neonatal period had reduced deep GM and 
WM volumes. There was no difference in brain volumes with regard to the type of SV 
morphology. Increased CSF volumes seem to represent a risk factor and early marker for 
neurodevelopmental impairment in children with SV CHD. Altered brain volumes may result 
from diffuse microstructural brain injury, underscoring the importance of volumetric 
measurements as a sensitive tool for the assessment of brain development. Assessments of our 
patient’s neurodevelopmental performance at school age will determine the long-term clinical 
impact of these early imaging findings. 
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Figure legends 
Figure 1.  Growth in children with single ventricle until Fontan completion  
Boxplots with median and interquartile range for Z-scores of growth indices of 44 children with 
single ventricle congenital heart disease at birth (A), at stage II surgery (B), and at the time of 
MRI scan prior to Fontan completion (C). White bars represent body weight, gray bars 
represent height and dark gray bars represent head circumference. Circles represent outliers. 
Horizontal lines show 2 SD of norm. Significant growth restriction is calculated by Student´s t-
test (*<0.05, **<0.001). 
 
Figure 2. Intracranial volumes in patients with and without neonatal 
cardiopulmonary bypass surgery  
The graphs show brain volumes before Fontan completion at two to three years of age, with 
median and interquartile range. Gray bars represent patients undergoing neonatal 
cardiopulmonary bypass (CPB) surgery (n=10) and white bars represent those operated beyond 
the neonatal period (n=34). Circles represent outliers. Significant differences between patients 
in deep gray matter volumes and white matter volumes are displayed (* < 0.05). P-values by 
Student´s t-test or Mann-Whitney-U test.  
 
Figure 3.  Association of intracranial volumes and Bayley-III Scales  
The graph shows the correlation of cerebrospinal fluid (CSF) volumes and total brain volumes 
(TBV) with neurodevelopmental outcome measured by the Bayley-III Scales. Results are given 
for the cognitive composite score (CCS) in A, for the language composite score (LCS) in B, 
and for the motor composite score (MCS) in C. Circles represent TBV with its legend on the 
left and triangles represent CSF volumes with its legend on the right (italic). Linear relation 
represented by Spearman’s correlation coefficient. Significant correlations between CSF and all 
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Bayley-III composite scales are represented as solid lines (p<0.05). Dashed line represent non-
significant correlations.  
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Tables  
Table 1. Patient characteristics 
 
 
 
 
 
 
 
 
 
Data are presented as n (%), mean ± SD (range) or median (IQR), n=44. 
 
  
Center A 23 (52.3) 
Male gender 28 (63.6) 
Socioeconomic status (total Score) 7 (7.9) 
Prenatal Diagnosis 25 (56.8) 
Gestation age at Birth, weeks 39.2 ± 1.5 
Apgar score at 5 minutes 9 (9.9) 
Umbilical cord pH 7.31 ± 0.09 
Birth weight, Z-score -0.37 ± 0.96 
Birth height, Z-score -0.69 ± 1.04  
Head circumference at birth, Z-score -0.42 ± 1.00 
Weight at Stage II, Z-score -1.79 ± 1.14 
Height at Stage II, Z-score -1.11 ± 1.57 
Head circumference at Stage II, Z-score -0.97 ± 1.30 
Weight at MRI, Z-score -0.45 ± 0.79  
Height at MRI, Z-score -0.90 ± 1.07 
Head circumference at MRI, Z-score 0.13 ± 0.99 
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Table 2. Intracranial volumes in children with single ventricle and healthy toddlers 
 
Data are presented as mean ± SD or median (IQR), n=44. Significant P-values by t-test for normally distributed data and by 
Mann-Whitney U test for non-normally distributed data.  
 
  
  CHD Control p-value 
 n=44 n=8  
Age at MRI, months 26.7 ± 3.9 29.8 ± 9.5 NS 
Total Intracranial volume (ICV), ml  909.1 ± 83.3 1028.3 ± 144.4 0.018 
Gray Matter volume, ml  610.5 ± 58.6 696.4 ± 86.2 0.017 
Deep Gray Matter volume, ml  42.7 ± 4.5 49.6 ± 6.7 0.012 
White Matter volume, ml 277.1 ± 29.6 330.9 ± 64.2 0.015 
Cerebrospinal fluid volume (CSF), ml  16.4 (13.1, 23.3) 12.7 (10.3, 14.5) 0.014 
CSF/ICV 0.017 (0.013, 0.024) 0.011 (0.009, 0.014) 0.001 
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Table 3. Intracranial volumes in relation to neurodevelopmental outcome  
 
 
 
 
 
 
 
 
 
 
 
 
* Significant linear relation indicated by Spearman’s Rho correlation coefficient (p<0.05), n=44.  
 
 
  
Bayley-III Scales 
Cognitive    Language    Motor 
Mild Motor  
Impairment 
  r Spearmann's Rho r Spearmann's Rho 
Total Intracranial Volume (ICV)    -0.06 0.08 0.08  0.13 
Global Gray Matter 0.06 0.20 0.19 -0.02 
Deep Gray Matter 0.11 0.29 0.24 -0.16 
Global White Matter    -0.10 0.17 0.06  0.08 
Cerebrospinal fluid (CSF) -0.31* -0.40* -0.31*   0.41* 
CSF/ICV    -0.30 -0.43* -0.33*   0.39* 
Head Circumference (2y)    -0.18    -0.17    -0.24  0.23 
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